UK Markets closed

Lerøy Seafood Group ASA (LYSFY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
17.700.00 (0.00%)
At close: 10:07AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close17.70
Open17.76
Bid0.00 x 0
Ask0.00 x 0
Day's range17.70 - 17.70
52-week range9.35 - 18.60
Volume20
Avg. volume9
Market cap5.27B
Beta (5Y monthly)0.51
PE ratio (TTM)34.84
EPS (TTM)0.51
Earnings dateN/A
Forward dividend & yield0.48 (2.70%)
Ex-dividend date03 Jun 2021
1y target estN/A
  • Globe Newswire

    Lerøy Seafood Group ASA: Successful placement of new senior unsecured green bonds

    Reference is made to the announcement 2 September 2021 regarding potential issuance of senior unsecured green bonds. Today, Lerøy Seafood Group ASA has successfully completed new senior unsecured green bond issues of NOK 500 million with maturity 17 September 2026, NOK 500 million with maturity 17 September 2027, and NOK 500 million with maturity 17 September 2031. The transaction was significantly oversubscribed. The bonds have a coupon of 3 months NIBOR + 1,00% per annum for the 5 year tranche

  • Globe Newswire

    Lerøy Seafood Group ASA: Green Bond Mandate Announcement and Fixed Income Investor Calls

    Lerøy Seafood Group ASA, rated BBB (stable) by Nordic Credit Rating, has mandated Danske Bank and DNB Markets as Global Coordinators and Green Bond Advisors, and Danske Bank, DNB Markets and Pareto Securities as Joint Lead Managers, to arrange a series of fixed income digital investor meetings on 8 September 2021. One or more NOK denominated senior unsecured green bond issues with tenors of 5 - 10 years, with preference for longer dated tenors, may follow, subject to inter alia market conditions

  • Globe Newswire

    Lerøy Seafood Group ASA: Results for Q2 and first half 2021

    SECOND QUARTER 2021 In Q2 2021, Lerøy Seafood Group (LSG) reported revenue of NOK 5,304 million, compared with NOK 4,712 million in the same period in 2020. Operating profit before fair value adjustment related to biological assets was NOK 583 million in Q2 2021, compared with NOK 303 million in Q2 2020. The gradual easing of restrictions linked to the COVID-19 pandemic in a number of key markets means stronger demand and higher prices realised. Higher prices realised, and improved productivity